BeOne Medicines Ltd. (ONC): Total Assets
$8.19B
As of 2025-12-31
$9.18B
As of 2026-06-30
+8.7%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.19B | +38.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $5.92B | +2.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $5.81B | -9.0% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $6.38B | -25.3% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $8.54B | n/c | 2023-02-27, Balance as of period end |
| 2020-12-31 | $5.60B | +247.4% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $1.61B | -28.3% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $2.25B | +115.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $1.05B | +157.9% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $405.81M | +247.5% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $116.76M | n/a | 2017-03-22, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $11.66B | -2.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $8.54B | -11.5% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.97B | +17.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $7.59B | +8.7% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.88B | +7.0% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.68B | +5.1% |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗